Spectrophotometric determination of niacin, thiamine, glibenclamide, erythromycin and para amino benzo ic acid using 2, 3 – dichloro – 5, 6 – dicyano – 1, 4 – benzoquinone
Table Of Contents
<p>
</p><p>Title page – – – – – – – – – – i<br>Declaration – – – – – – – – – – ii<br>Certification page – – – – – – – – iii<br>Dedication – – – – – – – – – iv<br>Acknowledgement – – – – – – – – v<br>Abstract – – – – – – – – – iv<br>Table of Contents – – – – – – – – ix<br>List of Figures – – – – – – – – – xxii<br>List of Tables – – – – – – – – – xxvii<br>Abbreviations– – – – – – – – – xxxiv<br>
Chapter ONE
<br>1.0 Introduction – – – – – – – 1<br>1.1 Charge transfer complexation- – – – – – 1<br>1.1.2 Analysis of Drugs – – – – – – 2<br>1.1.3 Justification of the study – – – – – – 6<br>1.1.4 Problem of the study – – – – – – – 6<br>1.1.5 Aims and Objectives- – – – – – – – 7<br>1.1.6 Scope of study- – – – – – – – 8<br>
Chapter TWO
<br>2.0 Literature Review – – – – – – – 9<br>2.1 Charge transfer complex – – – – – 9<br>2.1.1 Marcus theory- – – – – – – – – 11<br>ix<br>2.1.2 The one electron redox reaction – – – – – 11<br>2.1.3 The outer sphere electron transfer- – – – – – 12<br>2.2 Charge transfer transition energy – – – – – 13<br>2.3 Identification of CT bands – – – – – – 13<br>2.4 Spectroscopy – – – – – – – – 14<br>2.4.1 Different spectroscopic techniques – – – – – 14<br>2.4.2 Spectrophotometry – – – – – – 15<br>2.4.3 Major classes of spectrophotometer – – – – – 16<br>2.4.4 Terms used in U.V spectroscopy – – – – – 16<br>2.5 Absorption laws – – – – – – – 17<br>2.6 2,3- dichloro-5,6- dicyano-1, 4- benzoquinone – – – 18<br>2.6.1 Previous studies on DDQ- – – – – – – 20<br>2.7 Niacin (Pyridine – 3 – Carboxylic acid) – – – – 20<br>2.7.1 Previous studies on niacin – – – – – 21<br>2.8 Vitamin B1 (Thiamine Hydrochloride) – – – 22<br>2.8.1 Previous studies on thiamine hydrochloride- – – – 23<br>2.9 Glibenclamide – – – – – – – – 24<br>2.9.1 Previous studies on glibenclamide – – – – – 25<br>2.10 Erythromycin – – – – – – – – 26<br>2.10.1 Previous studies on erythromycin – — – – – 26<br>2.11 Para Aminobenzoic acid (PABA) – – – – – 28<br>2.11.1 Previous studies on PABA — – – – – – 28<br>x<br>
Chapter THREE
<br>3.0 Experimental – – – – – – – – 30<br>3.1 Materials and Methods – – – – – – 30<br>3.1.1 Drugs used and their sources – – – – – – 30<br>3.2 Preparation of reagents and standard solutions – – – 32<br>3.2.1 Preparation of 2, 3-dichloro-5, 6- dicyano 1,<br>4- benzoquinone – – – – – – – 32<br>3.2.2 Preparation of Standard solution of erythromycin – – – 32<br>3.2.3 Preparation of standard solution of glibenclamide – – – 32<br>3.2.4 Preparation of Standard solution of niacin – – – 32<br>3.2.5 Preparation of standard solutions of paraminobenzoic<br>acid (PABA) – – – – – – – – 33<br>3.2.6 Preparation of standard solutions of thiamine<br>hydrochloride – – – – – – – 33<br>3.3 Absorption spectra – – – – – – – – 33<br>3.3.1. Absorption spectra of 2,3- dichloro -5,6- dicyano -1,<br>4-benzoquinone – – – – – – – 33<br>3.3.2. Absorption spectra of erythromycin – – – – 33<br>3.3.3 Absorption spectra of glibenclamide – – – – 34<br>3.3.4 Absorption spectra of thiamine hydrochloride – – – 34<br>3.3.5 Absorption spectra of niacin – – – – – – 34<br>3.3.6 Absorption spectra of paraminobenzoic acid – – – 34<br>3.4.1 Absorption spectra of erythromycin-DDQ complex – – – 34<br>xi<br>3.4.2 Absorption spectra of glibenclamide-DDQ complex – – – 34<br>3.4.3 Absorption spectra of thiamine hydrochloride-DDQ<br>Complex – – – – – – — – 35<br>3.4.4 Absorption spectra of niacin-DDQ complex – – – 35<br>3.4.5 Absorption spectra of paraminobenzoic acid–DDQ<br>Complex – – – – – – – – 35<br>3.5 Stoichiometry of complexes – – – – – – 35<br>3.5.1 Stoichiometry of Erythromycin–DDQ Reaction – – – 35<br>3.5.2 Stoichiometry of Glibenclamide – DDQ Reaction – – – 36<br>3.5.3 Stoichiometry of Thiamine Hydrochloride – DDQ Reaction- – 36<br>3.5.4 Stoichiometry of Niacin-DDQ Reaction – – – – 36<br>3.5.5 Stoichiometry of PABA- DDQ Reaction – – – – 37<br>3.6 Effect of time on the formations of complexes- – – – 37<br>3.6.1 Effect of time on the formations of erythromycin–DDQ complex – 37<br>3.6.2 Effect of time on the formation of glibenclamide-DDQ complex – 37<br>3.6.3 Effect of time on the formation of thiamine<br>hydrochloride-DDQ complex – – – – – 38<br>3.6.4 Effect of time on the formation of PABA- DDQ Complex – – 38<br>3.6.5 Effect of time on the formation of niacin- DDQ complex — – 38<br>3.7 Effect of solvents on formation of complexes- – – – 38<br>3.7.1 Effect of solvents on erythromycin -DDQ complex – – – 38<br>3.7.2 Effect of solvents on glibenclamide – DDQ complex – – 39<br>3.7.3 Effect of solvents on complex formation of thiamine hydrochloride – 39<br>xii<br>3.7.4 Effect of solvents on niacin – DDQ complex – – – – 39<br>3.7.5 Effect of solvents on PABA- DDQ complex – – – – 40<br>3.8 Effect of temperature on formation complexes – – – 40<br>3.8.1 Effect of temperature on erythromycin-DDQ complex – – 40<br>3.8.2 Effect of temperature on glibenclamide-DDQ complex – – 40<br>3.8.3 Effect of temperature on thiamine- DDQ complex – – 40<br>3.8.4 Effect of temperature on niacin- DDQ complex – – – 41<br>3.8.5 Effect of temperature on PABA- DDQ complex – – – 41<br>3.9 pH study on formation of complexes – – – – – 41<br>3.9.1 pH study on erythromycin –DDQ complex – – – 41<br>3.9.3 pH study on glibenclamide-DDQ complex – – – – 41<br>3.9.4 pH study on thiamine hydrochloride-DDQ complex – – 41<br>3.9.5 pH study on niacin- DDQ complex – – — – – 42<br>3.9.6 pH study on PABA-DDQ complex – – — – – 42<br>3.10 Determination of association constant, molar absorptivity,<br>Free energy and Benesi- Hildebrand plot of the complexes- – 42<br>3.10.1 Benesi–Hildebrand plot of erythromycin-DDQ complex – – 42<br>3.10.2 Benesi- Hildebrand plot of glibenclamide- DDQ complex – – 42<br>3.10.3 Benesi – Hildebrand plot of thiamine hydrochloride-<br>DDQ complex – – – – – — – – 43<br>3.10.4 Benesi – Hildebrand plot of niacin –DDQ complex – – 43<br>3.10.5 Benesi-Hildebrand plot of PABA-DDQ complex – – – 44<br>3.2 Beer’s calibration plot for the formation of complexes – – 44<br>xiii<br>3.21 Beer’s calibration plot of erythromycin –DDQ complex – – 44<br>3.22 Beer’s calibration plot of glibenclamide –DDQ complex- – – 44<br>3.23 Beer’s calibration plot of PABA –DDQ complex – – – 45<br>3.24 Beer’s calibration plot of niacin-DDQ complex – – – 45<br>3.25 Beer’s calibration plot of thiamine–DDQ complex – – – 45<br>3.30 Interference studies on complex formation – – – – 46<br>3.31 Interference studies of erythromycin-DDQ complex – – – 46<br>3.32 Interference studies of thiamine hydrochloride-DDQ Complex – 46<br>3.33 Interference studies of niacin –DDQ complex – – – 46<br>3.34 Interference studies of PABA-DDQ complex – – – 47<br>3.35 Interference studies of glibenclamide-DDQ complex – – 47<br>3.40 Assay of dosage forms of drug samples – – – – – 47<br>3.41 Assay of dosage form of erythromycin drug – – – – 48<br>3.42 Assay of dosage form of glibenclamide drug – – – – 48<br>3.43 Assay of dosage form of thiamine drug- – – – – 48<br>3.44 Assay of dosage form of niacin drug – – – – 49<br>3.45 Assay of dosage form of PABA drug – – – – – 49<br>3.5 Kinetic measurements- – – – – – – 50<br>
Chapter FOUR
<br>4.1.1 Results – – – – – – – – – 52<br>4.1.2 Absorption spectra of the complex – – – – – 52<br>4.20 Stoichiometric relationship of erythromycin-DDQ Complex- – 81<br>4.21 Stoichiometric relation of glibenclamide –DDQ complex – – 81<br>xiv<br>4.22 Stoichiometric relationship of thiamine hydrochloride-DDQ complex – 81<br>4.23 Stoichiometric relationship of niacin-DDQ complex – – – 81<br>4.24 Stoichiometric relationship of PABA- DDQ complex- – – 81<br>4.30 Effect of time on the formation of complex – – – – 95<br>4.31 Maximum time for the formation of erythromycin-DDQ Complex – 95<br>4.32 Effects of time on glibenclamide-DDQ complex – – – 95<br>4.33 Effect of time on thiamine-DDQ complex – — – – 95<br>4.34 Effects of time on niacin-DDQ complex – — – – 95<br>4.35 Effects of time on PABA- DDQ complex – — – – 95<br>4.40 Effect of temperature on complexation- – – – – 108<br>4.41 Effect of temperature on the erythromycin-DDQ Complex – – 108<br>4.42 Effect of temperature on glibenclamide-DDQ Complex – – 108<br>4.43 Effects of temperature on thiamine hydrochloride-DDQ complex – 108<br>4.44 Effects of temperature on niacin-DDQ complex – – – 108<br>4.45 Effect of temperature on PABA- DDQ complex- – – – 109<br>4.50 pH studies of the complexes – – — – – – 120<br>4.51 pH study of erythromycin-DDQ complex — – – – 120<br>4.52 pH study of glibenclamide -DDQ complex – – – – 120<br>4.53 pH study of thiamine hydrochloride-DDQ complex – – – 120<br>4.54 pH study of niacin-DDQ complex – – – – – 120<br>4.55 pH study of PABA-DDQ complex – – – – – 120<br>4.6 Association constant, molar absorptivity, free gibb’s<br>energy, enthalpy and entropy changes of the complexes – – 131<br>xv<br>4.6.1 Association constant, molar absorptivity, free energy,<br>enthalpy and entropy changes of the erythromycin-DDQ complex – 131<br>4.6.2 Association constant, molar absorptivity, free energy,<br>enthalpy and entropy changes of the glibenclamide-DDQ complex – 142<br>4.6.3 Association constant, molar absorptivity, free energy,<br>enthalpy and entropy changes of the thiamine- DDQ complex – 152<br>4.6.4 Association constant, molar absorptivity, free energy,<br>enthalpy and entropy changes of the niacin- DDQ complex – 162<br>4.6.5 Association constant, molar absorptivity, free energy,<br>enthalpy and entropy changes of the PABA- DDQ complex – – 172<br>4.7 Beer’s calibration plots of the complexes – – 182<br>4.7.1 Beer’s calibration plot for erythromycin-DDQ Complex – – 182<br>4.7.2 Beer’s calibration plot for glibenclamide – – – – 184<br>4.7.3 Beer’s calibration plot of thiamine –DDQ complex – – – 186<br>4.7.4 Beer’s calibration plot for niacin-DDQ complex – – 188<br>4.7.5 Beer’s calibration plot for PABA-DDQ complex – – – 190<br>4.8.1 Recovery experiment of erythromycin-DDQ complex – – 192<br>4.8.2 Recovery experiment of glibenclamide-DDQ complex – – 195<br>4.8.3 Recovery experiment of thiamine-DDQ complex – – – 197<br>4.8.4 Recovery experiment of niacin-DDQ complex – – – – 199<br>4.8.5 Recovery experiment of PABA-DDQ complex – – – 201<br>4.9.1 Pharmaceutical interference studies on thiamine–DDQ complex – 203<br>4.9.2 Pharmaceutical interference studies on niacin –DDQ complex – 204<br>xvi<br>4.9.3 Pharmaceutical interference studies on glibenclamide–DDQ complex – 205<br>4.9.4 Pharmaceutical interference studies on PABA–DDQ Complex – 206<br>4.9.5 Pharmaceutical interference studies on erythromycin-DDQ complex 207<br>4.10 Determination of order of reactions – – – – – 208<br>4.10.1 Reaction of glibenclamide with DDQ – – – – 208<br>4.10.2 Reaction of erythromycin with DDQ- – – – – 211<br>4.10.3 Reaction of niacin with DDQ – – – – – 213<br>4.10.4 Reaction of PABA with DDQ – – – – – 216<br>4.10.5 Reaction of thiamine with DDQ – – – – – 219<br>4.10.6 Effect of temperatures on reaction rate of erythromycin-DDQ complex 222<br>4.10.7 Effect of temperatures on reaction rate of glibenclamide-DDQ complex 227<br>4.10.8 Effect of temperatures on reaction rate of niacin-DDQ Complex – 232<br>4.10.9 Effect of temperatures on reaction rate of PABA-DDQ Complex – 237<br>4.10.10 Effect of temperatures on reaction rate of thiamine-DDQ Complex 242<br>4.10.11 Effect of pH1-pH13 on reaction rate of erythromycin-DDQ Complex 248<br>4.10.12 Effect of pH1-pH13 on reaction rate of glibenclamide-DDQ complex 250<br>4.10.13 Effect of pH1-pH13 on reaction rate of niacin-DDQ complex – 252<br>4.10.14 Effect of pH1-pH13 on reaction rate of PABA-DDQ complex – 254<br>4.10.15 Effect of pH1-pH13 on reaction rate of thiamine – DDQ complex – 256<br>4.10.16 Effect of hydrogen ion concentration on reaction rate of – – 258<br>4.10.17 Effect of hydrogen ion concentration on reaction rate of PABA complex- 260<br>4.10.18 Effect of hydrogen ion concentration on reaction rate of niacin complex – 262<br>10.19 Effect of hydrogen ion concentration on reaction rate of<br>xvii<br>thiamine complex – – – – – – – – 264<br>4.10.20 Effect of hydrogen ion concentration on reaction rate of<br>erythromycin complex– – – – – – – 266<br>4.10.21 Effect of ionic strength on erythromycin-DDQ Complex – 268<br>4.10.22 Effect of ionic strength glibenclamide-DDQ Complex- – – 270<br>4.10.23 Effect of ionic strength on niacin-DDQ Complex– – — 272<br>4.10.24 Effect of ionic strength on PABA-DDQ Complex- – – 274<br>4.10.25 Effect of ionic strength on thiamine-DDQ Complex- – – 276<br>4.10.26 Rate determining Steps of drugs-DDQ complex – – – 278<br>4.10.27 Infrared frequencies and tentative assignments for drugs and reagent – 282<br>
Chapter FIVE
<br>5.0 .1 Discussion- – – – – – – – 287<br>5.0.2 Absorption Spectra- – – – – – – – 287<br>5.0.3 Absorption spectra of erythromycin complex- – – – 288<br>5.0.4 Absorption spectra of erythromycin in different solvent- – – 299<br>5.0.5 Absorption spectra of glibenclamide complex- – – – 290<br>5.0.6 Absorption spectra of glibenclamide in different solvent – – 291<br>5.0.7 Absorption spectra of thiamine complex- – – – – 292<br>5.0.8 Absorption spectra of thiamine in different solvent- – – – 293<br>5.0.9 Absorption spectra of niacin complex- – – – – 293<br>5.0.10 Absorption spectra of niacin in different solvent- – – – 294<br>5.0.11 Absorption spectra of PABA complex- – – – 294<br>5.0.12 Absorption spectra of PABA in different solvent- – – – 295<br>xviii<br>5.1 Stoichiometric relationship of erythromycin-DDQ Complex- – 296<br>5.1.1 Stoichiometric relation of glibenclamide –DDQ complex – – 296<br>5.1.2 Stoichiometric relationship of thiamine hydrochloride-DDQ complex 296<br>5.1.3 Stoichiometric relationship of niacin-DDQ complex — – – 297<br>5.1.4 Stoichiometric relationship of PABA- DDQ complex – – 297<br>5.2 Effect of time on the formation of complex – – – – 297<br>5.2.1 Maximum time for the formation of erythromycin-DDQ Complex – 297<br>5.2.2 Effects of time on glibenclamide-DDQ complex – – – 297<br>5.2.3 Effect of time on thiamine-DDQ complex – – – – 298<br>5.2.4 Effects of time on niacin-DDQ complex – – – – 298<br>5.2.5 Effects of time on PABA- DDQ complex – – – – 298<br>5.3 Effect of temperature on complexation – – – – 298<br>5.3.1 Effect of temperature on the erythromycin-DDQ Complex – – 298<br>5.3.2 Effect of temperature on glibenclamide-DDQ Complex- – – 299<br>5.3.3 Effects of temperature on thiamine hydrochloride- DDQ complex – 299<br>5.3.4 Effects of temperature on niacin-DDQ complex – – – 300<br>5.3.5 Effect of temperature on PABA- DDQ complex – – – 300<br>5.4 pH studies of the complexes – – – – – – 301<br>5.4.1 pH study of erythromycin-DDQ complex – – – – 301<br>5.4.2 pH study of glibenclamide -DDQ complex – – – – 301<br>5.4.3 pH study of thiamine hydrochloride-DDQ complex – – – 301<br>5.4.4 pH study of niacin-DDQ complex – – – – – 301<br>5.4.5 Effect of pH medium on the formation of PABA-DDQ complex – 302<br>xix<br>5.5 Association constant, molar absorptivity, free Gibb’s energy, enthalpy<br>and entropy changes for the formation of the complexes – – 302<br>5.5.1 Association constant, molar absorptivity, free energy,<br>enthalpy and entropy changes of the erythromycin-DDQ complex – 302<br>5.5.2 Association constant, molar absorptivity, free energy,<br>enthalpy and entropy changes of the glibenclamide-DDQ complex – 303<br>5.5.3 Association constant, molar absorptivity, free energy,<br>enthalpy and entropy changes of the thiamine- DDQ complex – 304<br>5.5.4 Association constant, molar absorptivity, free energy,<br>enthalpy and entropy changes of the niacin- DDQ complex – 305<br>5.5.5 Association constant, molar absorptivity, free energy, enthalpy and<br>entropy changes of the PABA- DDQ complex – – – 305<br>5.6 Beer’s calibration plots for the formation of the complexes – – 306<br>5.6.1 Beer’s calibration plot for the formation of erythromycin – DDQ complex – 306<br>5.6.2 Beer’s calibration plot for the formation of glibenclamide-DDQ complex – 306<br>5.6.3 Beer’s calibration plot for the formation of thiamine – DDQ complex – 306<br>5.6.4 Beer’s calibration plot for the formation of niacin – DDQ complex – 307<br>5.6.5 Beer’s calibration plot for the formation of PABA – DDQ complex – 307<br>5.7.1 Recovery studies on the formation of erythromycin-DDQ reaction – 307<br>5.7.2 Recovery studies on the formation of glibenclamide-DDQ reaction- 307<br>5.7.3 Recovery studies on the formation of thiamine-DDQ reaction – 308<br>5.7.4 Recovery studies on the formation of niacin-DDQ reaction – – 308<br>5.7.5 Recovery studies on the formation of PABA-DDQ reaction- – 308<br>xx<br>5.8.1 Interference studies on the formation of thiamine–DDQ complex – 308<br>5.8.2 Interference studies on the formation of niacin – DDQ complex – 309<br>5.8.3 Interference studies on the formation of PABA –DDQ complex 311<br>5.8.4 Interference studies on the formation of PABA –DDQ complex – 313<br>5.8.5 Interference studies on the formation of erythromycin -DDQ complex 313<br>5.8.6 Kinetics measurement – – – – – – 315<br>5.8.7 Determination of order of reactions – – – – – 315<br>5.8.8 Determination of order of reactions – – – – – 317<br>5.8.9 Determination of order of reactions – – – – – 318<br>5.8.10 Determination of order of reactions – – – – – 320<br>5.8.11 Determination of order of reactions – – – – – 321<br>5.8.12 FTIR characterization of the complexes – – – – 322<br>Chapter Six<br>6.0. Conclusion and Recommendation- – – – – – 323<br>References – – – – – – – – – 326<br>Appendix – – – – – – – – – – 339</p><p> </p>
<br><p></p>
Project Abstract
<p>
</p><p>A simple and sensitive spectrophotometric method is described for the assay of the<br>drugs; niacin, glibenclamide, erythromycin, thiamine and 4-aminobenzoic acid. The<br>method is based on charge transfer complexation (CT) reaction of niacin, glibenclamide,<br>erythromycin, thiamine and 4-aminobenzoic acid as n-electron donors with 2,3-<br>dichloro-5,6-dicyno-1,4-benzoquinone(DDQ) as л-electron acceptor in methanol.<br>Intensely coloured charge transfer complexes with niacin (reddish brown, lmax ;464 nm;<br>εmax, 1.02×103 dm3mol-1cm-1) thiamine (reddish brown ,lmax ;474 nm; εmax, 1.08×103<br>dm3mol-1cm-1), glibenclamide (reddish brown , lmax ;474 nm; εmax,0.99×103 dm3mol-<br>1cm-1) erythromycin(reddish brown , lmax ;464 nm; εmax, 1.27×103 dm3mol-1cm-1) 4-<br>aminobenzoic acid(reddish brown, lmax ;474nm; εmax, 1.06×103 dm3mol-1cm-1) all in a<br>11 stoichiometric ratio. Condition for complete reactions and optimum stability of<br>complexes were niacin (70 min, 60 OC) thiamine (25 min, 40 OC), glibenclamide (35<br>min, 40 OC), erythromycin (15 min, 60 OC) and 4-aminobenzoic acid (15 min, 60 OC) as<br>absorbances of the complexes remained invariant within these conditions. Formation<br>and stability of the complexes of niacin, thiamine, 4-aminobenzoic acid and<br>erythromycin were optimum at pH 8. For glibenclamide pH 2.0 favoured optimum<br>stability and formation. The bands distinguished for the donors to donor-acceptor CT<br>complexes displayed small changes in band intensities and frequency values in the IR<br>spectra ,The –NH2 group vibration occurring at 3609 cm-1 shifted to 3610 cm-1 in<br>thiamine, PABA (3222 cm-1 to 3183 cm-1), ѵ (N-H) occurring at 3331cm-1 shifted to<br>3371 cm-1 in glibenclamide, ѵ(C= N) occurring at 2936 cm-1 shifted to 2944 cm-1 in<br>niacin, ѵ (CH3-N) occurring at 2948 cm-1 shifted to 2939 cm-1 in erythromycin. The<br>vi<br>vibration ѵ (C= O) of DDQ observed at 1665 cm-1 shifted to 1669 cm-1 in the CT<br>complex for thiamine, PABA(1665 cm-1 to 1670 cm-1), glibenclamide(1675 cm-1 to<br>1676 cm-1), erythromycin(1665 cm-1 to 1674 cm-1), niacin(1665 cm-1 to 1655 cm-1)<br>respectively. Adherence to Beer’s Law was within the concentration range for niacin (5-<br>130 μg/cm3), thiamine (5-80 μg/cm3), glibenclamide (9-100 μg/cm3), erythromycin<br>(5-150 μg/cm3), 4-aminobenzoic acid(5-90 μg/cm3). Limit of detection and<br>quantification of the drugs based on this method is niacin (1.78 and 5.4), thiamine (1.23<br>and 3.37), glibenclamide (3.47 and 10.5), erythromycin (2.11 and 6.40), 4-aminobenzoic<br>acid (0.55 and 1.67) respectively. Evaluation of the degree of interference by excipients<br>used in the drugs manufactured indicates tolerance to certain concentrations. A detailed<br>study on the interference of different excipients was made. No significant interference<br>was observed in magnesium stearate (30 μg/cm3), Talc (15-25μg/cm3, 35-40 μg/cm3)<br>with thiamine-DDQ complex. There were no significant interference in stearic acid (35<br>μg/cm3) but tolerable interference was seen in magnesium stearate (20 μg/cm3) and<br>calcium phosphate (15 μg/cm3) with niacin-DDQ complex. For glibenclamide – DDQ<br>complex, no significant interference was seen with calcium phosphate (30 μg/cm3) but<br>there were tolerable interference present in stearic acid (40 μg/cm3). In 4-aminobenzoic<br>acid, no significant interference was observed with magnesium stearate (30 μg/cm3) and<br>talc (35 -40μg/cm3) but tolerable interference was observed in corn starch (15 μg/cm3).<br>Also no significant interference was seen in corn starch (35 μg/cm3) with erythromycin-<br>DDQ complex but there was tolerable interference in talc (10 μg/cm3). The Pearson<br>correlation coefficient for the compliance of the method as regards the pure and<br>commercial forms of niacin, thiamine, glibenclamide, erythromycin and 4-aminobenzoic<br>vii<br>acids are 0.993, 0.977, 0.987, 0.998 and 0.993 respectively which shows significance<br>with p < 0.01. The analysis of variance test revealed the non-significance of niacin,<br>thiamine, glibenclamide, erythromycin and 4-aminobenzoic acid with p > 0.01. The<br>mean percentage recoveries were 98.94 ± 0.016, 96.2 ± 0.016, 98.24 ± 0.011, 107.4<br>± 0.023 and 102.35 ± 0.014 for niacin, thiamine, glibenclamide, erythromycin and 4-<br>aminobenzoic acid respectively. Kinetics of the reactions infer that the rate of formation<br>of the CT complexes did not vary significantly with increase in concentration of<br>glibenclamide, erythromycin, thiamine, niacin and 4-aminobenzoic acid indicating<br>likely zeroth order dependence of the rate with respect to concentration of the drugs.<br>However, the linearity of the pseudo-first order plot points to first order dependence of<br>rate on [DDQ].The overall rate equation for the reactions can be given as<br>− ı[ııı]<br>ıı = ıııı [ııı]<br>Based on the limit of detection and quantification, adherence to Beer-Lambert’s<br>law and low degree of interference, the method is recommended for the analysis of these<br>drugs.</p><p> </p><p> </p>
<br><p></p>
Project Overview
<p>
1.0 Introduction<br>1.1 Charge Transfer Complexation<br>Acceptors are aromatic systems containing electron withdrawing substituents<br>such as nitro, cyano and halogen groups (Foster, 1967). Electron donors are systems<br>that are electron rich (Ajali and Chukwurah, 2001). The interaction between electron<br>donor and electron acceptor results in formation of charge transfer complex (Ajali et al,<br>2008). The term charge transfer denotes a certain type of complex which results from<br>interaction of an electron acceptor and an electron donor with the formation of weak<br>bonds (Hassib and Issa, 1996). However the nature of the interaction in a charge<br>transfer complex is not a stable chemical bond and is much weaker than covalent<br>forces. It is better characterized as a weak electron resonance. As a result, the excitation<br>energy of this resonance occurs very frequently in the visible region of the<br>electromagnetic spectrum. This produces the usually intense colour characteristic for<br>these complexes. These optical absorption bands are often referred to as charge transfer<br>bands. Molecular interactions between electron donors and acceptors are generally<br>associated with the formation of intensely coloured charge transfer complexes which<br>absorb radiation in the visible region.Charge transfer (CT) complexes have been widely<br>studied (Ezeanokete et al, 2013; Hala et al, 2013; Frag et al, 2011; Ramzin et al, 2012;<br>Farha, 2013). Charge transfer complexes are known to take part in many chemical<br>reactions like addition, substitution and condensation reactions (Van et al, 2006).<br>Donor acceptor properties are prerequisites for the formation of charge transfer<br>complexes. Most drugs have –NH or –NH2 groups which behave as bases (electron<br>donors) and could form complexes with acids (electron acceptor).Various cases have<br>been reported. The charge-transfer complexes formed between the ephedrine (Eph)<br>2<br>drug as a donor with picric acid (Pi) and quinol (QL) as ı–acceptors have been<br>synthesized in methanol as a solvent at room temperature and spectroscopically studied<br>as shown in scheme 1:<br>HO<br>N<br>CH3<br>O<br>H2<br>CH3<br>OH<br>[(EPh) (QL)] Complex<br>HO<br>OH<br>HO<br>N<br>CH3<br>H<br>CH3<br>Quinol Ephedrine<br>+<br>Scheme 1: Interaction of Ephedrine with Quinol to form the charge transfer<br>complex<br>Spectrophotometry is widely used to monitor the progress of reactions and the position<br>of equilibrium. Its measurement is often straight forward to make and the technique is<br>sensitive and precise provided that relevant limitations (such as the regions over which<br>Beer’s law is valid) are recognized. Spectrophotometric technique continues to be the<br>most preferred methods for routine analytical work due to their simplicity and<br>reasonable sensitivity with significant economical advantages (Raza, 2006).<br>1.1.2: Analysis of Drugs<br>A spectrophotometric method has been employed for the determination of<br>allopuriol using DDQ through charge transfer formation. The absorption spectra of<br>allopuriol-DDQ complex in acetonitrile solvent showed three maxima at (ÊŽmax = 450<br>nm; ε1 = 1.95 x103 Lmol-1cm-1), 540 nm (ε2 = 0.80 x 103 Lmol-1cm-1) and 580 nm<br>3<br>(ε3 = 0.69 x 103 Lmol-1cm-1) with a 1:1 stoichiometric ratio between allopuriol and<br>DDQ. The charge transfer complex formation is shown in scheme 2:<br>Cl<br>O<br>NC<br>NC<br>O<br>Cl<br>N<br>N<br>NH<br>O<br>H<br>Allopurinol<br>DDQ<br>O O<br>Cl Cl<br>HN<br>N<br>N N<br>N<br>NH<br>O<br>Allopurinol -DDQ Charge Transfer Complex<br>+ +<br>Scheme 2: Interaction of Allopurinol with DDQ to form the charge transfer complex<br>DDQ (2,3 – dichloro – 5, 6 – dicyano -p- benzoquinone) acts as an oxidizing<br>(Braude et al, 1956) as well as dehydrating agent in synthetic organic chemistry. It is<br>known for its interaction with drugs having donor sites in their structures and form Ion-<br>Pair charge transfer complexes which offers a basis for quantification of drugs<br>(Ghabsha et al, 2007; Vmsi and Gowri, 2008; Rehman et al, 2008; Rahman and Kashif,<br>2005; Khaled, 2008; Walash, 2004; El-Ragehy et al, 1997). DDQ as π-electron<br>acceptors often forms highly coloured electron-donor, electron-acceptor or CT<br>complexes with various donors which provide the possibility of determination of drugs<br>by spectrophotometric methods.<br>Vitamin B1 (Thiamine) has its chemical name as 2-[3-[(4-Amino-2-methyl- pyrimidin-<br>5-yl) methyl] -4-methyl – thiazol – 5 – yl] ethanol. Vitamin B1 is a water soluble<br>vitamin. It plays an important biological role in the metabolic process of the<br>carbohydrate in the human body (Khaled, 2008). Previous studies have utilized<br>different techniques for the estimation of thiamine hydrochloride which includes:<br>4<br>normal flow injection (Mouayed, 2012), electrochemical analysis method (Akyilmaz<br>and Dinckaya, 2006) high performance liquid chromato graphy (Ghasemi, 2005)<br>spectrofluorimetry (Hassan, 2001) polarimetry. Also direct spectrophotometric method<br>has been described for the determination of thiamine hydrochloride in the presence of<br>its degradation products (Wahbi et al, 1981).<br>Vitamin B3 (Niacin) chemically designated as [pyridine -3- carboxylic acid] is one of<br>the water soluble vitamins of the B-complex. It is an essential vitamin that is widely<br>available in drug and health food stores. Niacin is sometimes prescribed in high<br>dosages to lower cholesterol. People also take niacin supplements because they think<br>niacin helps ease gastrointestinal disturbances. It is widely distributed among plants<br>and animals. Some analytical methods have been developed for determination of niacin<br>which includes HPLC, flow injection TLC (Sarangi et al, 1985) HPTLC (Tiwari, 2010;<br>Zarzycki et al, 1995; Hsieh, 2005).<br>Furthermore, Spectrophotometric methods have been reported for the<br>simultaneous estimation of Atorvastation and niacin based on simultaneous equation<br>and absorbance ratio method (Sawart et al, 2012).<br>PABA [4-aminobenzoic acid] was used as a component of some medicines e.g<br>analgesic or anesthetic preparations, sunscreen agents and bentiromide (Imondi et al,<br>1972; Cyr et al, 1976; Charles et al, 1977).<br>It is an essential factor for the growth of bacteria. It is possessed of an antisulfanilamide<br>activity (Zhang et al, 2005). Various methods used for the analysis of<br>PABA include HPLC (Zhang et al, 2005) GC (Zhou and Zhang, 1998; Schmidt et al,<br>1997; Lambropoulon, 2002). Spectrophotometric methods have been used for the<br>determination of PABA; most of the methods are based on diazotization of PABA and<br>coupling the corresponding agent such as Braton Marshall reagent (Othaman and<br>5<br>Mansor, 2005), 4–dimethylaminobenzaldehyde (Yamato and Kinoshita, 1979), N-(Inapthyl)<br>ethylediamine dihydrochloride (Fister and Drazin, 1973) and phyloroglucinol<br>(Othaman and Mansor, 2005).Indirect spectrophotometric method for the determination<br>of PABA has been reported (Salvandor et al, 2003).A flow injection<br>spectrophotometric determination of propoxur with diazotized- 4-aminobenzoic acid<br>oxidation (Mirick, 1943) methods has been reported.<br>Erythromycin (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R) – 4-[(2,6-dideoxy -3- Cmethyl-<br>3-o-methyl-a-L-ribo-hexopy-ransoyl) oxy] – 14 – ethyl – 7 , 12 , 13 –<br>trihydroxy -3,5,7,9,11,13-hexamethyl- 6 – [ ( 3 , 4 , 6 – trideoxy – 3 – dimethylamino–β-<br>D-xylo-hexopyranosyl)-oxy]oxa cyclotetradecane -2, 10- dione is a macrolide<br>antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of<br>penicillin. It has better coverage of a typical organism and occasional used as a<br>prokinetic agent. It inhibits bacterial reproduction but does not kill bacterial cells.<br>Literature revealed different techniques for the analysis of the studied macrolides.<br>The British Pharmacopeia stated the liquid chromatography method for the assay of<br>erythromycin. Other method of analysis includes spectrofluormetry (Pakinaz, 2002)<br>and (Nawal et al, 2006) capillary electrophoresis HPLC (Maria and Britt, 1995;<br>Dubois et al, 2001; Ramakrishna et al, 2005) voltametry (Faryhaly and Mohammed,<br>2004) microbiological method (Bernabaeu et al, 1999), spectrophotometry (Tasmin et<br>al, 2008; Carlos et al, 2010; Safwan Roula, 2012; Magar et al, 2012).<br>Glibenclamide chemically known as 5-chloro-n-[2-[4[(cyclohexylamino)<br>carbonyl] -amino] sulphonyl] phenyl] –ethyl] -2-methoxy benzamide is a second<br>generation sulphonyl ureas drug widely used in treatment of type 2 diabetic patient<br>(Parmeswararo et al, 2012). The literature survey shows that spectrophotometric<br>methods have been employed for the determination of glibenclamide based on<br>6<br>derivatization technique or coupling with another reagent (Nalwaya, 2008), (Bediar et<br>al, 1990; Lopez et al, 2005; Goweri et al, 2005; Martins, et al, 2007; Gianotto et<br>al,2007) High pressure liquid chromatography methods are the most commonly used<br>for the determination of glibenclamide and different methods coupled with UV<br>detection. Fluorescence (Khtri et al, 2001) detection or mass spectrometry (Smgh and<br>Taylor, 1996) .Thin layer chromatography has been employed for the detection of<br>glibenclamide (Kumasak et al, 2005), voltametric method (Radi, 2004).<br>Spectrofluorimetric method have all been reported. Erythromycin, thiamine, niacin,<br>p-Aminobenzoic acid, and glibenclamide are all bases with –NH2 or –NH groups<br>which have donor sites and can form charge transfer complexes.<br>1.1.3 Justification of the Study<br>In order to solve the problem of fake drugs which is rampart in Nigeria, there is<br>need for a method of drug analysis which is simple, fast and cost effective. However,<br>this new method of analysis will bring about easier analysis of drugs that is simple, fast<br>and of low cost which will invariably reduce importation and manufacture of<br>substandard drugs in Nigeria.<br>Secondly, the new method will solve the problem of interferences caused by<br>drug excipients.<br>1.1.4: Problem of the Study<br>These drugs are easily adulterated due to their nature and their high demand. This<br>requires that their degree of purity be certified before usage. Also the methods used in<br>determining these drugs like the flow injection spectrophotometric method , High<br>performance liquid chromatography, voltammetry, polarimetry and spectrofluorimetry<br>all require costly equipment, laborious, involve rigid pH control and use large amounts<br>7<br>of organic solvents which are expensive, hazardous to health and harmful to the<br>environment. Methods like spectrophotometry based on charge transfer complexation,<br>which are fast, less laborious and economical, are required for the assay of these drugs.<br>1.1.5 Aims and Objectives<br>The aim of this research was to determine a method based on formation of CT<br>complex between the drugs and DDQ that is simple, fast, economical and less<br>laborious. The objectives of this research are to:<br>(i) establish the degree of CT complex formation between the drugs and DDQ<br>(ii) determine the stability of the CT complexes with respect to time, temperature<br>and pH.<br>(iii) apply the CT complexes in spectrophotometric determinations of the drug<br>(iv) determine the average recoveries of the drugs in pure and commercial forms<br>(v) validate the proposed method using International Conference on<br>Harmonization Guideline.<br>(vi) determination of the kinetic model for the charge transfer complexation<br>reactions.<br>(vii) characterization of the CT complex using Fourier transformer infra red<br>spectrometer.<br>8<br>1.1.6: Scope of Study<br>• U.V Absorption spectra<br>• I.R Absorption spectra<br>• Establishment of ı-max<br>• Stoichiometric relationships<br>• Optimum conditions(time , temperature , pH)<br>• Establishment of standard curves<br>• Applying the charge transfer complex in the spectrophotometric determination<br>of the drugs<br>• Validation of the proposed method using international conference on<br>harmonization guidelines<br>• Statistical analysis (One-way analysis of variance and Pearson correlation<br>coefficient)<br>• Determination of order of reactions (zero and 1st order)<br>• Characterization of charge transfer complexes using Fourier transformer infra<br>red spectrometer.
<br></p>